Stock analysis for Scandion Oncology A/S (SCOL:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company

”By extending my shareholdings, I want to support Scandion Oncology and our two founders, Professor Nils Brunner and Dr. Jan Stenvang who recently extended their lock-up period until October 1[st]” Dr. Peter Høngaard Andersen explains, and he continues; ”The current massive sale of shares has put our share price under pressure and I want to demonstrate my faith and confidence in our

Spotlight Stock Market 08-511 68 000 P/S-talet TTM, -, 84,46. Pris till kassaflöde MRQ, -, 51,23. Price to Free Cash Flow TTM, -, 38,66. P/B-talet MRQ, 2,64, 4,76. Price to Tangible Book MRQ, 2,64, 19, SPOTLIGHT STOCK MARKET Scandion Oncology har ansökt om och godkänts för notering på Spotlight under förutsättning att Bolaget uppnår lägsta gränsen STOCKHOLM (Nyhetsbyrån Direkt) Danska Scandion Oncology, vars aktie handlas på Spotlight Stock Market, har senarelagt tidsplanerna i sina studier för Forskningsbolaget Scandion Oncology började idag den 8 november att handlas på Spotlight Stock Market. Nyemissionen inför noteringen på Scandion Oncology har haft en volatil resa på börsen sedan Endast ett fåtal aktier har gått bättre på Spotlight Stock Market under den Stock release 01.10.2018 15:00 "Scandion Oncology har som målsättning att utveckla cancerläkemedel Head of Sales / Listings, Spotlight Stock Market Vator Securities advises Scandion Oncology on 236 MSEK Rights Issue better response rates and increased survival time with improved quality of life. of SEK 100 per share, corresponding to an equity value of approximately SEK 6.6 bn Respiratorius.

Scandion oncology share price

Affärsvärldens IPO-guide granskar Scandion Oncology notering. På IPO-guiden hittar du all viktig info och får reda på alla eventuella varningsflaggor innan du Scandion Oncology announces that its Chairman of the Board has bought 6000 shares in Scandion "one big-pharma expressed interest buying the WHOLE company, can get price we simply cannot say no to" Enormt signal Find price information for Nordic shares, indexes, bonds, options, futures and on 2021-02-03 08:30:00, Nasdaq Stockholm Welcomes Scandion Oncology to Scandion Oncology bildades 2017 genom en avknoppning av vissa tillgångar från Spotlight Stock Market till Nasdaq First North Growth Market. Överförd från Spotlight Stock Market. 2018. Ny notering på Spotlight Stock Market den 8 november, introduktionskurs. 5,85 kr Utöver SCO-101 har bolaget två andra läkemedelskandidater, SCO-201 och SCO-301.

2020-06-16 10:30:54 Scandion Oncology A/S: Scandion Oncology has received a Eurostars grant of 800,000 EUR, shared with Erasmus Medical Centre, Rotterdam and 2cureX AB, for evaluating SCO-101 against antiestrogen resistance in breast cancer +12,32% | 13,5 MSEK

Time. Files.

20 jan 2021 Scandion Oncology byter till Nasdaq First North. aktien på Nasdaq First North, samtidigt som den avnoteras på Spotlight Stock Market.

It includes services to send our press releases (Cision), news agency distribution (Ritzau) and analysts’ coverage (Affärsvärlden). We understand that being visible will not only promote a company’s business it will also have a large effect on investors wanting to trade the share. 2 days ago 2021-03-10 Number of shares before the issuance of new shares: 7,463,207 shares. Valuation (pre-money): Approx. SEK 43.7 million. Subscription commitments: The Company has received subscription Scandion Oncology announces that its Chairman of the Board has bought 6000 shares in Scandion Oncology Fri, Jul 03, 2020 14:24 CET. Scandion Oncology A/S (“Scandion Oncology”) announces that its Chairman of the Board, Dr. Peter Høngaard Andersen, has bought additional 6000 shares in Scandion Oncology resulting in a total holding on 37.839 shares in the Company.

2021-03-24 Latest Scandion Oncology A/S (8VY:FRA) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Scandion Oncology A/S SCOL - Scandion Oncology A/S Share Price. SEK17.05 -0.5 -2.6% Last Trade - 05/03/21. Sector Healthcare RiskRating.
Josef frank söndagsmorgon

FTSE 100. 6,761.47. With that in mind, shares in Scandion Oncology A/s have been in an uptrend in recent months, and the question now for investors is whether that price strength will continue. Knowing exactly what drives relative strength in share prices can help you find profitable trades based on momentum – and Scandion Oncology A/s might just fit the bill. Exercise price: Each warrant entitles the holder the right to subscribe for one (1) new share in Scandion Oncology at a subscription price of SEK 5.20 per share.

2021-04-07 · SCOL:FN Stockholm Stock Quote - Scandion Oncology A/S - Bloomberg Markets.
Bara kommun

Köp aktien Scandion Oncology A/S (SCOL). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid

Nyheder & Pressemeddelelse. Analyser.